Condition: Perimenopause · PMDD · Sponsor: Texas Christian University
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
This description comes directly from the study's public registry record.
Sarah E Hill, PhD · 817-257-6424 · s.e.hill@tcu.edu
Savannah A Hastings, M.S. · 817-257-4989 · s.a.hastings@tcu.edu
Always discuss trial participation with your own doctor first.
| Texas Christian University | Fort Worth, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07688720